Exploring the morphology of the host cell to open new possibilities for drug repurposing in viral infections Article Swipe
Marianna Tampere
,
Adelinn Kalman
,
Jonne Rietdijk
,
Hanna Axelsson
,
Duncan Njenda
,
Jayasankar Mohanakrishnan Kaimal
,
Maris Lapins
,
Flavio Ballante
,
Trang Le
,
Anna Bäckström
,
Brinton Seashore‐Ludlow
,
Emma Lundberg
,
Ola Spjuth
,
Jordi Carreras‐Puigvert
,
Charlotte Stadler
,
Päivi Östling
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.58647/rexpo.23000018.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.58647/rexpo.23000018.v1
New approaches are needed to identify novel or repurposed drugs to treat deadly viral infections. Majority of screening methods evaluate the drug activity on a given virus while neglecting the host mechanisms and responses to the virus infection.Here, we investigate antiviral activity of 5200 compounds from the SPECS drug repurposing library by three distinct screening campaigns: 1) host cell morphology changes by phenomics assay Cell Painting 2) antibody-detection of SARS-CoV-3 infection and 3) the gold-standard cytopathic effect method. We demonstrate how SARS-CoV-2 infection induced a specific phenotypic signature in Vero E6 cells, which was reversed by assay controls such as remdesivir. Our unbiased host-focused approach identified additional 324 compounds with antiviral activity against SARS-CoV-2. To further study the host response during infection, we quantified the subcellular localization and expression of 602 host proteins using antibodies from the Human Protein Atlas. We identified phenotypic responses to SARS-CoV-2 infection in 97 proteins. Finally, to broaden the paradigm of how antiviral therapies are identified we aim to combine these host-focused screening approaches. Our preliminary analyses have identified 3 host proteins linked to 3 compounds that reverse the virus-specific phenotype, which all represent novel drug repurposing candidates against SARS-CoV-2. Taken together, these findings illustrate a new host-centric approach for the discovery of antivirals and could be applied for other emerging or re-emerging viruses.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.58647/rexpo.23000018.v1
- https://drugrepocentral.scienceopen.com/document_file/5c784034-e987-4d37-85b3-5a18ad23c501/ScienceOpen/RExPO23_abstract_Tampere.pdf
- OA Status
- gold
- References
- 1
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4387176633
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4387176633Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.58647/rexpo.23000018.v1Digital Object Identifier
- Title
-
Exploring the morphology of the host cell to open new possibilities for drug repurposing in viral infectionsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-09-28Full publication date if available
- Authors
-
Marianna Tampere, Adelinn Kalman, Jonne Rietdijk, Hanna Axelsson, Duncan Njenda, Jayasankar Mohanakrishnan Kaimal, Maris Lapins, Flavio Ballante, Trang Le, Anna Bäckström, Brinton Seashore‐Ludlow, Emma Lundberg, Ola Spjuth, Jordi Carreras‐Puigvert, Charlotte Stadler, Päivi ÖstlingList of authors in order
- Landing page
-
https://doi.org/10.58647/rexpo.23000018.v1Publisher landing page
- PDF URL
-
https://drugrepocentral.scienceopen.com/document_file/5c784034-e987-4d37-85b3-5a18ad23c501/ScienceOpen/RExPO23_abstract_Tampere.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://drugrepocentral.scienceopen.com/document_file/5c784034-e987-4d37-85b3-5a18ad23c501/ScienceOpen/RExPO23_abstract_Tampere.pdfDirect OA link when available
- Concepts
-
Drug repositioning, Repurposing, Phenotypic screening, Biology, Host (biology), Virology, Drug discovery, Phenotype, Computational biology, Virus, Vero cell, Drug, Bioinformatics, Gene, Genetics, Pharmacology, EcologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
1Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4387176633 |
|---|---|
| doi | https://doi.org/10.58647/rexpo.23000018.v1 |
| ids.doi | https://doi.org/10.58647/rexpo.23000018.v1 |
| ids.openalex | https://openalex.org/W4387176633 |
| fwci | 0.0 |
| type | article |
| title | Exploring the morphology of the host cell to open new possibilities for drug repurposing in viral infections |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10118 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9987999796867371 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[1].id | https://openalex.org/T12576 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9908999800682068 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | vaccines and immunoinformatics approaches |
| topics[2].id | https://openalex.org/T10167 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.984499990940094 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2713 |
| topics[2].subfield.display_name | Epidemiology |
| topics[2].display_name | Influenza Virus Research Studies |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C103637391 |
| concepts[0].level | 3 |
| concepts[0].score | 0.8090407848358154 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q5308921 |
| concepts[0].display_name | Drug repositioning |
| concepts[1].id | https://openalex.org/C519536355 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7373912930488586 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q21021151 |
| concepts[1].display_name | Repurposing |
| concepts[2].id | https://openalex.org/C6555983 |
| concepts[2].level | 4 |
| concepts[2].score | 0.6247720718383789 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q7181398 |
| concepts[2].display_name | Phenotypic screening |
| concepts[3].id | https://openalex.org/C86803240 |
| concepts[3].level | 0 |
| concepts[3].score | 0.6223115921020508 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[3].display_name | Biology |
| concepts[4].id | https://openalex.org/C126831891 |
| concepts[4].level | 2 |
| concepts[4].score | 0.605462372303009 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q221673 |
| concepts[4].display_name | Host (biology) |
| concepts[5].id | https://openalex.org/C159047783 |
| concepts[5].level | 1 |
| concepts[5].score | 0.5417384505271912 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[5].display_name | Virology |
| concepts[6].id | https://openalex.org/C74187038 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5314473509788513 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1418791 |
| concepts[6].display_name | Drug discovery |
| concepts[7].id | https://openalex.org/C127716648 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4772351086139679 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q104053 |
| concepts[7].display_name | Phenotype |
| concepts[8].id | https://openalex.org/C70721500 |
| concepts[8].level | 1 |
| concepts[8].score | 0.4751327335834503 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[8].display_name | Computational biology |
| concepts[9].id | https://openalex.org/C2522874641 |
| concepts[9].level | 2 |
| concepts[9].score | 0.47487589716911316 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q808 |
| concepts[9].display_name | Virus |
| concepts[10].id | https://openalex.org/C89138240 |
| concepts[10].level | 3 |
| concepts[10].score | 0.4195511043071747 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q3066564 |
| concepts[10].display_name | Vero cell |
| concepts[11].id | https://openalex.org/C2780035454 |
| concepts[11].level | 2 |
| concepts[11].score | 0.3674974739551544 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[11].display_name | Drug |
| concepts[12].id | https://openalex.org/C60644358 |
| concepts[12].level | 1 |
| concepts[12].score | 0.2214704155921936 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q128570 |
| concepts[12].display_name | Bioinformatics |
| concepts[13].id | https://openalex.org/C104317684 |
| concepts[13].level | 2 |
| concepts[13].score | 0.14165055751800537 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[13].display_name | Gene |
| concepts[14].id | https://openalex.org/C54355233 |
| concepts[14].level | 1 |
| concepts[14].score | 0.1071266233921051 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[14].display_name | Genetics |
| concepts[15].id | https://openalex.org/C98274493 |
| concepts[15].level | 1 |
| concepts[15].score | 0.08557498455047607 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[15].display_name | Pharmacology |
| concepts[16].id | https://openalex.org/C18903297 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7150 |
| concepts[16].display_name | Ecology |
| keywords[0].id | https://openalex.org/keywords/drug-repositioning |
| keywords[0].score | 0.8090407848358154 |
| keywords[0].display_name | Drug repositioning |
| keywords[1].id | https://openalex.org/keywords/repurposing |
| keywords[1].score | 0.7373912930488586 |
| keywords[1].display_name | Repurposing |
| keywords[2].id | https://openalex.org/keywords/phenotypic-screening |
| keywords[2].score | 0.6247720718383789 |
| keywords[2].display_name | Phenotypic screening |
| keywords[3].id | https://openalex.org/keywords/biology |
| keywords[3].score | 0.6223115921020508 |
| keywords[3].display_name | Biology |
| keywords[4].id | https://openalex.org/keywords/host |
| keywords[4].score | 0.605462372303009 |
| keywords[4].display_name | Host (biology) |
| keywords[5].id | https://openalex.org/keywords/virology |
| keywords[5].score | 0.5417384505271912 |
| keywords[5].display_name | Virology |
| keywords[6].id | https://openalex.org/keywords/drug-discovery |
| keywords[6].score | 0.5314473509788513 |
| keywords[6].display_name | Drug discovery |
| keywords[7].id | https://openalex.org/keywords/phenotype |
| keywords[7].score | 0.4772351086139679 |
| keywords[7].display_name | Phenotype |
| keywords[8].id | https://openalex.org/keywords/computational-biology |
| keywords[8].score | 0.4751327335834503 |
| keywords[8].display_name | Computational biology |
| keywords[9].id | https://openalex.org/keywords/virus |
| keywords[9].score | 0.47487589716911316 |
| keywords[9].display_name | Virus |
| keywords[10].id | https://openalex.org/keywords/vero-cell |
| keywords[10].score | 0.4195511043071747 |
| keywords[10].display_name | Vero cell |
| keywords[11].id | https://openalex.org/keywords/drug |
| keywords[11].score | 0.3674974739551544 |
| keywords[11].display_name | Drug |
| keywords[12].id | https://openalex.org/keywords/bioinformatics |
| keywords[12].score | 0.2214704155921936 |
| keywords[12].display_name | Bioinformatics |
| keywords[13].id | https://openalex.org/keywords/gene |
| keywords[13].score | 0.14165055751800537 |
| keywords[13].display_name | Gene |
| keywords[14].id | https://openalex.org/keywords/genetics |
| keywords[14].score | 0.1071266233921051 |
| keywords[14].display_name | Genetics |
| keywords[15].id | https://openalex.org/keywords/pharmacology |
| keywords[15].score | 0.08557498455047607 |
| keywords[15].display_name | Pharmacology |
| language | en |
| locations[0].id | doi:10.58647/rexpo.23000018.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://drugrepocentral.scienceopen.com/document_file/5c784034-e987-4d37-85b3-5a18ad23c501/ScienceOpen/RExPO23_abstract_Tampere.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | proceedings-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Exploring the morphology of the host cell to open new possibilities for drug repurposing in viral infections |
| locations[0].landing_page_url | https://doi.org/10.58647/rexpo.23000018.v1 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5031972205 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5744-3206 |
| authorships[0].author.display_name | Marianna Tampere |
| authorships[0].countries | SE |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I2800139495, https://openalex.org/I28166907 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Oncology and Pathology and Science for Life Laboratory, Karolinska Institutet, S-171 76, Stockholm, Sweden |
| authorships[0].institutions[0].id | https://openalex.org/I28166907 |
| authorships[0].institutions[0].ror | https://ror.org/056d84691 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I28166907 |
| authorships[0].institutions[0].country_code | SE |
| authorships[0].institutions[0].display_name | Karolinska Institutet |
| authorships[0].institutions[1].id | https://openalex.org/I2800139495 |
| authorships[0].institutions[1].ror | https://ror.org/04ev03g22 |
| authorships[0].institutions[1].type | facility |
| authorships[0].institutions[1].lineage | https://openalex.org/I2800139495 |
| authorships[0].institutions[1].country_code | SE |
| authorships[0].institutions[1].display_name | Science for Life Laboratory |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Marianna Tampere |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Oncology and Pathology and Science for Life Laboratory, Karolinska Institutet, S-171 76, Stockholm, Sweden |
| authorships[1].author.id | https://openalex.org/A5111047898 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-1539-0633 |
| authorships[1].author.display_name | Adelinn Kalman |
| authorships[1].countries | SE |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2800139495, https://openalex.org/I28166907 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Oncology and Pathology and Science for Life Laboratory, Karolinska Institutet, S-171 76, Stockholm, Sweden |
| authorships[1].institutions[0].id | https://openalex.org/I28166907 |
| authorships[1].institutions[0].ror | https://ror.org/056d84691 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I28166907 |
| authorships[1].institutions[0].country_code | SE |
| authorships[1].institutions[0].display_name | Karolinska Institutet |
| authorships[1].institutions[1].id | https://openalex.org/I2800139495 |
| authorships[1].institutions[1].ror | https://ror.org/04ev03g22 |
| authorships[1].institutions[1].type | facility |
| authorships[1].institutions[1].lineage | https://openalex.org/I2800139495 |
| authorships[1].institutions[1].country_code | SE |
| authorships[1].institutions[1].display_name | Science for Life Laboratory |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Adelinn Kalman |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Oncology and Pathology and Science for Life Laboratory, Karolinska Institutet, S-171 76, Stockholm, Sweden |
| authorships[2].author.id | https://openalex.org/A5063974642 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-3799-6684 |
| authorships[2].author.display_name | Jonne Rietdijk |
| authorships[2].countries | SE |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I123387679, https://openalex.org/I2800139495 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, SE-75124, Uppsala, Sweden. |
| authorships[2].institutions[0].id | https://openalex.org/I2800139495 |
| authorships[2].institutions[0].ror | https://ror.org/04ev03g22 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I2800139495 |
| authorships[2].institutions[0].country_code | SE |
| authorships[2].institutions[0].display_name | Science for Life Laboratory |
| authorships[2].institutions[1].id | https://openalex.org/I123387679 |
| authorships[2].institutions[1].ror | https://ror.org/048a87296 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I123387679 |
| authorships[2].institutions[1].country_code | SE |
| authorships[2].institutions[1].display_name | Uppsala University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Jonne Rietdijk |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, SE-75124, Uppsala, Sweden. |
| authorships[3].author.id | https://openalex.org/A5022662144 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-2365-1749 |
| authorships[3].author.display_name | Hanna Axelsson |
| authorships[3].countries | SE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I2800139495, https://openalex.org/I28166907 |
| authorships[3].affiliations[0].raw_affiliation_string | Chemical Biology Consortium Sweden (CBCS), Science for Life Laboratory, Karolinska Institutet, S-17176, Stockholm, Sweden. |
| authorships[3].institutions[0].id | https://openalex.org/I28166907 |
| authorships[3].institutions[0].ror | https://ror.org/056d84691 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I28166907 |
| authorships[3].institutions[0].country_code | SE |
| authorships[3].institutions[0].display_name | Karolinska Institutet |
| authorships[3].institutions[1].id | https://openalex.org/I2800139495 |
| authorships[3].institutions[1].ror | https://ror.org/04ev03g22 |
| authorships[3].institutions[1].type | facility |
| authorships[3].institutions[1].lineage | https://openalex.org/I2800139495 |
| authorships[3].institutions[1].country_code | SE |
| authorships[3].institutions[1].display_name | Science for Life Laboratory |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Hanna Axelsson |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Chemical Biology Consortium Sweden (CBCS), Science for Life Laboratory, Karolinska Institutet, S-17176, Stockholm, Sweden. |
| authorships[4].author.id | https://openalex.org/A5069340320 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-8276-9726 |
| authorships[4].author.display_name | Duncan Njenda |
| authorships[4].countries | SE |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I28166907 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, S-17176, Stockholm, Sweden. |
| authorships[4].institutions[0].id | https://openalex.org/I28166907 |
| authorships[4].institutions[0].ror | https://ror.org/056d84691 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I28166907 |
| authorships[4].institutions[0].country_code | SE |
| authorships[4].institutions[0].display_name | Karolinska Institutet |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Duncan Njenda |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, S-17176, Stockholm, Sweden. |
| authorships[5].author.id | https://openalex.org/A5060228276 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Jayasankar Mohanakrishnan Kaimal |
| authorships[5].countries | SE |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I2800139495 |
| authorships[5].affiliations[0].raw_affiliation_string | Division of Cellular and Clinical Proteomics, Science for Life Laboratory, Kungliga Tekniska Högskolan, SE-17121 Solna, Sweden |
| authorships[5].institutions[0].id | https://openalex.org/I2800139495 |
| authorships[5].institutions[0].ror | https://ror.org/04ev03g22 |
| authorships[5].institutions[0].type | facility |
| authorships[5].institutions[0].lineage | https://openalex.org/I2800139495 |
| authorships[5].institutions[0].country_code | SE |
| authorships[5].institutions[0].display_name | Science for Life Laboratory |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Jayasankar Mohanakrishnan Kaimal |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Division of Cellular and Clinical Proteomics, Science for Life Laboratory, Kungliga Tekniska Högskolan, SE-17121 Solna, Sweden |
| authorships[6].author.id | https://openalex.org/A5064016167 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-0122-6680 |
| authorships[6].author.display_name | Maris Lapins |
| authorships[6].countries | SE |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I123387679, https://openalex.org/I2800139495 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, SE-75124, Uppsala, Sweden. |
| authorships[6].institutions[0].id | https://openalex.org/I2800139495 |
| authorships[6].institutions[0].ror | https://ror.org/04ev03g22 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I2800139495 |
| authorships[6].institutions[0].country_code | SE |
| authorships[6].institutions[0].display_name | Science for Life Laboratory |
| authorships[6].institutions[1].id | https://openalex.org/I123387679 |
| authorships[6].institutions[1].ror | https://ror.org/048a87296 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I123387679 |
| authorships[6].institutions[1].country_code | SE |
| authorships[6].institutions[1].display_name | Uppsala University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Maris Lapins |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, SE-75124, Uppsala, Sweden. |
| authorships[7].author.id | https://openalex.org/A5004266252 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-4831-3423 |
| authorships[7].author.display_name | Flavio Ballante |
| authorships[7].countries | SE |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I2800139495, https://openalex.org/I28166907 |
| authorships[7].affiliations[0].raw_affiliation_string | Chemical Biology Consortium Sweden (CBCS), Science for Life Laboratory, Karolinska Institutet, S-17176, Stockholm, Sweden |
| authorships[7].institutions[0].id | https://openalex.org/I28166907 |
| authorships[7].institutions[0].ror | https://ror.org/056d84691 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I28166907 |
| authorships[7].institutions[0].country_code | SE |
| authorships[7].institutions[0].display_name | Karolinska Institutet |
| authorships[7].institutions[1].id | https://openalex.org/I2800139495 |
| authorships[7].institutions[1].ror | https://ror.org/04ev03g22 |
| authorships[7].institutions[1].type | facility |
| authorships[7].institutions[1].lineage | https://openalex.org/I2800139495 |
| authorships[7].institutions[1].country_code | SE |
| authorships[7].institutions[1].display_name | Science for Life Laboratory |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Flavio Ballante |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Chemical Biology Consortium Sweden (CBCS), Science for Life Laboratory, Karolinska Institutet, S-17176, Stockholm, Sweden |
| authorships[8].author.id | https://openalex.org/A5075058787 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-1106-2034 |
| authorships[8].author.display_name | Trang Le |
| authorships[8].countries | SE |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I2800139495 |
| authorships[8].affiliations[0].raw_affiliation_string | Division of Cellular and Clinical Proteomics, Science for Life Laboratory, Kungliga Tekniska Högskolan, SE-17121 Solna, Sweden |
| authorships[8].institutions[0].id | https://openalex.org/I2800139495 |
| authorships[8].institutions[0].ror | https://ror.org/04ev03g22 |
| authorships[8].institutions[0].type | facility |
| authorships[8].institutions[0].lineage | https://openalex.org/I2800139495 |
| authorships[8].institutions[0].country_code | SE |
| authorships[8].institutions[0].display_name | Science for Life Laboratory |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Trang H. Le |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Division of Cellular and Clinical Proteomics, Science for Life Laboratory, Kungliga Tekniska Högskolan, SE-17121 Solna, Sweden |
| authorships[9].author.id | https://openalex.org/A5017034476 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-3390-8456 |
| authorships[9].author.display_name | Anna Bäckström |
| authorships[9].countries | SE |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I2800139495 |
| authorships[9].affiliations[0].raw_affiliation_string | Division of Cellular and Clinical Proteomics, Science for Life Laboratory, Kungliga Tekniska Högskolan, SE-17121 Solna, Sweden |
| authorships[9].institutions[0].id | https://openalex.org/I2800139495 |
| authorships[9].institutions[0].ror | https://ror.org/04ev03g22 |
| authorships[9].institutions[0].type | facility |
| authorships[9].institutions[0].lineage | https://openalex.org/I2800139495 |
| authorships[9].institutions[0].country_code | SE |
| authorships[9].institutions[0].display_name | Science for Life Laboratory |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Anna Bäckström |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Division of Cellular and Clinical Proteomics, Science for Life Laboratory, Kungliga Tekniska Högskolan, SE-17121 Solna, Sweden |
| authorships[10].author.id | https://openalex.org/A5051159339 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-8658-5967 |
| authorships[10].author.display_name | Brinton Seashore‐Ludlow |
| authorships[10].countries | SE |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I2800139495, https://openalex.org/I28166907 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Oncology and Pathology and Science for Life Laboratory, Karolinska Institutet, S-171 76, Stockholm, Sweden |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I2800139495, https://openalex.org/I28166907 |
| authorships[10].affiliations[1].raw_affiliation_string | Chemical Biology Consortium Sweden (CBCS), Science for Life Laboratory, Karolinska Institutet, S-17176, Stockholm, Sweden. |
| authorships[10].institutions[0].id | https://openalex.org/I28166907 |
| authorships[10].institutions[0].ror | https://ror.org/056d84691 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I28166907 |
| authorships[10].institutions[0].country_code | SE |
| authorships[10].institutions[0].display_name | Karolinska Institutet |
| authorships[10].institutions[1].id | https://openalex.org/I2800139495 |
| authorships[10].institutions[1].ror | https://ror.org/04ev03g22 |
| authorships[10].institutions[1].type | facility |
| authorships[10].institutions[1].lineage | https://openalex.org/I2800139495 |
| authorships[10].institutions[1].country_code | SE |
| authorships[10].institutions[1].display_name | Science for Life Laboratory |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Brinton Seashore-Ludlow |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Chemical Biology Consortium Sweden (CBCS), Science for Life Laboratory, Karolinska Institutet, S-17176, Stockholm, Sweden., Department of Oncology and Pathology and Science for Life Laboratory, Karolinska Institutet, S-171 76, Stockholm, Sweden |
| authorships[11].author.id | https://openalex.org/A5052101351 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-7034-0850 |
| authorships[11].author.display_name | Emma Lundberg |
| authorships[11].countries | SE |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I2800139495 |
| authorships[11].affiliations[0].raw_affiliation_string | Division of Cellular and Clinical Proteomics, Science for Life Laboratory, Kungliga Tekniska Högskolan, SE-17121 Solna, Sweden |
| authorships[11].institutions[0].id | https://openalex.org/I2800139495 |
| authorships[11].institutions[0].ror | https://ror.org/04ev03g22 |
| authorships[11].institutions[0].type | facility |
| authorships[11].institutions[0].lineage | https://openalex.org/I2800139495 |
| authorships[11].institutions[0].country_code | SE |
| authorships[11].institutions[0].display_name | Science for Life Laboratory |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Emma Lundberg |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Division of Cellular and Clinical Proteomics, Science for Life Laboratory, Kungliga Tekniska Högskolan, SE-17121 Solna, Sweden |
| authorships[12].author.id | https://openalex.org/A5046663348 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-8083-2864 |
| authorships[12].author.display_name | Ola Spjuth |
| authorships[12].countries | SE |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I123387679, https://openalex.org/I2800139495 |
| authorships[12].affiliations[0].raw_affiliation_string | Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, SE-75124, Uppsala, Sweden. |
| authorships[12].institutions[0].id | https://openalex.org/I2800139495 |
| authorships[12].institutions[0].ror | https://ror.org/04ev03g22 |
| authorships[12].institutions[0].type | facility |
| authorships[12].institutions[0].lineage | https://openalex.org/I2800139495 |
| authorships[12].institutions[0].country_code | SE |
| authorships[12].institutions[0].display_name | Science for Life Laboratory |
| authorships[12].institutions[1].id | https://openalex.org/I123387679 |
| authorships[12].institutions[1].ror | https://ror.org/048a87296 |
| authorships[12].institutions[1].type | education |
| authorships[12].institutions[1].lineage | https://openalex.org/I123387679 |
| authorships[12].institutions[1].country_code | SE |
| authorships[12].institutions[1].display_name | Uppsala University |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Ola Spjuth |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, SE-75124, Uppsala, Sweden. |
| authorships[13].author.id | https://openalex.org/A5070109614 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-7671-3707 |
| authorships[13].author.display_name | Jordi Carreras‐Puigvert |
| authorships[13].countries | SE |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I123387679, https://openalex.org/I2800139495 |
| authorships[13].affiliations[0].raw_affiliation_string | Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, SE-75124, Uppsala, Sweden. |
| authorships[13].institutions[0].id | https://openalex.org/I2800139495 |
| authorships[13].institutions[0].ror | https://ror.org/04ev03g22 |
| authorships[13].institutions[0].type | facility |
| authorships[13].institutions[0].lineage | https://openalex.org/I2800139495 |
| authorships[13].institutions[0].country_code | SE |
| authorships[13].institutions[0].display_name | Science for Life Laboratory |
| authorships[13].institutions[1].id | https://openalex.org/I123387679 |
| authorships[13].institutions[1].ror | https://ror.org/048a87296 |
| authorships[13].institutions[1].type | education |
| authorships[13].institutions[1].lineage | https://openalex.org/I123387679 |
| authorships[13].institutions[1].country_code | SE |
| authorships[13].institutions[1].display_name | Uppsala University |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Jordi Carreras-Puigvert |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, SE-75124, Uppsala, Sweden. |
| authorships[14].author.id | https://openalex.org/A5005605525 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-6781-1938 |
| authorships[14].author.display_name | Charlotte Stadler |
| authorships[14].countries | SE |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I2800139495 |
| authorships[14].affiliations[0].raw_affiliation_string | Division of Cellular and Clinical Proteomics, Science for Life Laboratory, Kungliga Tekniska Högskolan, SE-17121 Solna, Sweden |
| authorships[14].institutions[0].id | https://openalex.org/I2800139495 |
| authorships[14].institutions[0].ror | https://ror.org/04ev03g22 |
| authorships[14].institutions[0].type | facility |
| authorships[14].institutions[0].lineage | https://openalex.org/I2800139495 |
| authorships[14].institutions[0].country_code | SE |
| authorships[14].institutions[0].display_name | Science for Life Laboratory |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Charlotte Stadler |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Division of Cellular and Clinical Proteomics, Science for Life Laboratory, Kungliga Tekniska Högskolan, SE-17121 Solna, Sweden |
| authorships[15].author.id | https://openalex.org/A5078078476 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-5501-466X |
| authorships[15].author.display_name | Päivi Östling |
| authorships[15].countries | SE |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I2800139495, https://openalex.org/I28166907 |
| authorships[15].affiliations[0].raw_affiliation_string | Department of Oncology and Pathology and Science for Life Laboratory, Karolinska Institutet, S-171 76, Stockholm, Sweden |
| authorships[15].institutions[0].id | https://openalex.org/I28166907 |
| authorships[15].institutions[0].ror | https://ror.org/056d84691 |
| authorships[15].institutions[0].type | education |
| authorships[15].institutions[0].lineage | https://openalex.org/I28166907 |
| authorships[15].institutions[0].country_code | SE |
| authorships[15].institutions[0].display_name | Karolinska Institutet |
| authorships[15].institutions[1].id | https://openalex.org/I2800139495 |
| authorships[15].institutions[1].ror | https://ror.org/04ev03g22 |
| authorships[15].institutions[1].type | facility |
| authorships[15].institutions[1].lineage | https://openalex.org/I2800139495 |
| authorships[15].institutions[1].country_code | SE |
| authorships[15].institutions[1].display_name | Science for Life Laboratory |
| authorships[15].author_position | last |
| authorships[15].raw_author_name | Päivi Östling |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Department of Oncology and Pathology and Science for Life Laboratory, Karolinska Institutet, S-171 76, Stockholm, Sweden |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://drugrepocentral.scienceopen.com/document_file/5c784034-e987-4d37-85b3-5a18ad23c501/ScienceOpen/RExPO23_abstract_Tampere.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Exploring the morphology of the host cell to open new possibilities for drug repurposing in viral infections |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10118 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9987999796867371 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 and COVID-19 Research |
| related_works | https://openalex.org/W2299074827, https://openalex.org/W4387074703, https://openalex.org/W3159848998, https://openalex.org/W4285506882, https://openalex.org/W4318481850, https://openalex.org/W4281726759, https://openalex.org/W3134564766, https://openalex.org/W3044296243, https://openalex.org/W4386219807, https://openalex.org/W2518384400 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.58647/rexpo.23000018.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://drugrepocentral.scienceopen.com/document_file/5c784034-e987-4d37-85b3-5a18ad23c501/ScienceOpen/RExPO23_abstract_Tampere.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | proceedings-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Exploring the morphology of the host cell to open new possibilities for drug repurposing in viral infections |
| best_oa_location.landing_page_url | https://doi.org/10.58647/rexpo.23000018.v1 |
| primary_location.id | doi:10.58647/rexpo.23000018.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://drugrepocentral.scienceopen.com/document_file/5c784034-e987-4d37-85b3-5a18ad23c501/ScienceOpen/RExPO23_abstract_Tampere.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | proceedings-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Exploring the morphology of the host cell to open new possibilities for drug repurposing in viral infections |
| primary_location.landing_page_url | https://doi.org/10.58647/rexpo.23000018.v1 |
| publication_date | 2023-09-28 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W4220797957 |
| referenced_works_count | 1 |
| abstract_inverted_index.3 | 179, 184 |
| abstract_inverted_index.a | 27, 87, 205 |
| abstract_inverted_index.1) | 59 |
| abstract_inverted_index.2) | 69 |
| abstract_inverted_index.3) | 75 |
| abstract_inverted_index.97 | 153 |
| abstract_inverted_index.<p | 0, 117 |
| abstract_inverted_index.E6 | 93 |
| abstract_inverted_index.We | 81, 145 |
| abstract_inverted_index.as | 102 |
| abstract_inverted_index.be | 216 |
| abstract_inverted_index.by | 54, 64, 98 |
| abstract_inverted_index.in | 91, 152 |
| abstract_inverted_index.of | 19, 45, 71, 134, 160, 212 |
| abstract_inverted_index.on | 26 |
| abstract_inverted_index.or | 10, 221 |
| abstract_inverted_index.to | 7, 13, 37, 149, 156, 168, 183 |
| abstract_inverted_index.we | 41, 127, 166 |
| abstract_inverted_index.324 | 110 |
| abstract_inverted_index.602 | 135 |
| abstract_inverted_index.Our | 104, 174 |
| abstract_inverted_index.aim | 167 |
| abstract_inverted_index.all | 192 |
| abstract_inverted_index.and | 35, 74, 132, 214 |
| abstract_inverted_index.are | 5, 164 |
| abstract_inverted_index.for | 209, 218 |
| abstract_inverted_index.how | 83, 161 |
| abstract_inverted_index.new | 206 |
| abstract_inverted_index.the | 23, 32, 38, 49, 76, 122, 129, 141, 158, 188, 210 |
| abstract_inverted_index.was | 96 |
| abstract_inverted_index.5200 | 46 |
| abstract_inverted_index.Cell | 67 |
| abstract_inverted_index.Vero | 92 |
| abstract_inverted_index.cell | 61 |
| abstract_inverted_index.drug | 24, 51, 195 |
| abstract_inverted_index.from | 48, 140 |
| abstract_inverted_index.have | 177 |
| abstract_inverted_index.host | 33, 60, 123, 136, 180 |
| abstract_inverted_index.such | 101 |
| abstract_inverted_index.that | 186 |
| abstract_inverted_index.with | 112 |
| abstract_inverted_index.Human | 142 |
| abstract_inverted_index.SPECS | 50 |
| abstract_inverted_index.Taken | 200 |
| abstract_inverted_index.assay | 66, 99 |
| abstract_inverted_index.could | 215 |
| abstract_inverted_index.drugs | 12 |
| abstract_inverted_index.given | 28 |
| abstract_inverted_index.novel | 9, 194 |
| abstract_inverted_index.other | 219 |
| abstract_inverted_index.study | 121 |
| abstract_inverted_index.these | 170, 202 |
| abstract_inverted_index.three | 55 |
| abstract_inverted_index.treat | 14 |
| abstract_inverted_index.using | 138 |
| abstract_inverted_index.viral | 16 |
| abstract_inverted_index.virus | 29, 39 |
| abstract_inverted_index.which | 95, 191 |
| abstract_inverted_index.while | 30 |
| abstract_inverted_index.Atlas. | 144 |
| abstract_inverted_index.cells, | 94 |
| abstract_inverted_index.deadly | 15 |
| abstract_inverted_index.during | 125 |
| abstract_inverted_index.effect | 79 |
| abstract_inverted_index.linked | 182 |
| abstract_inverted_index.needed | 6 |
| abstract_inverted_index.Protein | 143 |
| abstract_inverted_index.against | 115, 198 |
| abstract_inverted_index.applied | 217 |
| abstract_inverted_index.broaden | 157 |
| abstract_inverted_index.changes | 63 |
| abstract_inverted_index.combine | 169 |
| abstract_inverted_index.further | 120 |
| abstract_inverted_index.induced | 86 |
| abstract_inverted_index.library | 53 |
| abstract_inverted_index.method. | 80 |
| abstract_inverted_index.methods | 21 |
| abstract_inverted_index.reverse | 187 |
| abstract_inverted_index.Finally, | 155 |
| abstract_inverted_index.Majority | 18 |
| abstract_inverted_index.Painting | 68 |
| abstract_inverted_index.activity | 25, 44, 114 |
| abstract_inverted_index.analyses | 176 |
| abstract_inverted_index.approach | 107, 208 |
| abstract_inverted_index.controls | 100 |
| abstract_inverted_index.distinct | 56 |
| abstract_inverted_index.emerging | 220 |
| abstract_inverted_index.evaluate | 22 |
| abstract_inverted_index.findings | 203 |
| abstract_inverted_index.identify | 8 |
| abstract_inverted_index.paradigm | 159 |
| abstract_inverted_index.proteins | 137, 181 |
| abstract_inverted_index.response | 124 |
| abstract_inverted_index.reversed | 97 |
| abstract_inverted_index.specific | 88 |
| abstract_inverted_index.unbiased | 105 |
| abstract_inverted_index.viruses. | 223 |
| abstract_inverted_index.antiviral | 43, 113, 162 |
| abstract_inverted_index.compounds | 47, 111, 185 |
| abstract_inverted_index.discovery | 211 |
| abstract_inverted_index.infection | 73, 85, 151 |
| abstract_inverted_index.phenomics | 65 |
| abstract_inverted_index.proteins. | 154 |
| abstract_inverted_index.represent | 193 |
| abstract_inverted_index.responses | 36, 148 |
| abstract_inverted_index.screening | 20, 57, 172 |
| abstract_inverted_index.signature | 90 |
| abstract_inverted_index.therapies | 163 |
| abstract_inverted_index.together, | 201 |
| abstract_inverted_index.SARS-CoV-2 | 84, 150 |
| abstract_inverted_index.SARS-CoV-3 | 72 |
| abstract_inverted_index.additional | 109 |
| abstract_inverted_index.antibodies | 139 |
| abstract_inverted_index.antivirals | 213 |
| abstract_inverted_index.approaches | 4 |
| abstract_inverted_index.campaigns: | 58 |
| abstract_inverted_index.candidates | 197 |
| abstract_inverted_index.cytopathic | 78 |
| abstract_inverted_index.dir="auto" | 2, 118 |
| abstract_inverted_index.expression | 133 |
| abstract_inverted_index.identified | 108, 146, 165, 178 |
| abstract_inverted_index.illustrate | 204 |
| abstract_inverted_index.infection, | 126 |
| abstract_inverted_index.mechanisms | 34 |
| abstract_inverted_index.morphology | 62 |
| abstract_inverted_index.neglecting | 31 |
| abstract_inverted_index.phenotype, | 190 |
| abstract_inverted_index.phenotypic | 89, 147 |
| abstract_inverted_index.quantified | 128 |
| abstract_inverted_index.repurposed | 11 |
| abstract_inverted_index.SARS-CoV-2. | 116, 199 |
| abstract_inverted_index.approaches. | 173 |
| abstract_inverted_index.demonstrate | 82 |
| abstract_inverted_index.infections. | 17 |
| abstract_inverted_index.investigate | 42 |
| abstract_inverted_index.preliminary | 175 |
| abstract_inverted_index.re-emerging | 222 |
| abstract_inverted_index.remdesivir. | 103 |
| abstract_inverted_index.repurposing | 52, 196 |
| abstract_inverted_index.subcellular | 130 |
| abstract_inverted_index.host-centric | 207 |
| abstract_inverted_index.host-focused | 106, 171 |
| abstract_inverted_index.localization | 131 |
| abstract_inverted_index.class="first" | 1 |
| abstract_inverted_index.gold-standard | 77 |
| abstract_inverted_index.virus-specific | 189 |
| abstract_inverted_index.infection.Here, | 40 |
| abstract_inverted_index.antibody-detection | 70 |
| abstract_inverted_index.id="d12710397e279">To | 119 |
| abstract_inverted_index.id="d12710397e277">New | 3 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 16 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8299999833106995 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.19297614 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |